Expression of DNMT3A is highly variable in CLL cells; nevertheless, lower DNMT3A expression is associated with a more aggressive disease, presenting a shorter failure-free survival. The gene discussed is DNMT3A; the disease is B-cell chronic lymphocytic leukemia.